CNQ · BETR.CN
BetterLife Pharma Inc.
CA$0.25+CA$0.00 (0.0%)
BetterLife Pharma Inc.’s quoted price sits in the upper half of its reported 52-week range, 45.65% below the high.
Loading market information…
OTC · NSHSF · USD
Stock price
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
NanoSphere Health Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 68.94% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
NanoSphere Health Sciences Inc. operates as a nano-biotechnology enterprise, concentrating on the provision of biologically active compounds throughout both the United States and Canada. Its principal offering is the NanoSphere Deliver System, an advanced platform that leverages nanotechnology to enhance the biological absorption of supplements, nutraceuticals, and non-prescription drugs. This innovative system serves various industries, including cannabis, pharmaceuticals, and animal health. Established in 2005, the company maintains its corporate headquarters in Vancouver, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:08 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$0.25+CA$0.00 (0.0%)
BetterLife Pharma Inc.’s quoted price sits in the upper half of its reported 52-week range, 45.65% below the high.
$0.01+$0.00 (+0.82%)
ProText Mobility, Inc.’s quoted price sits in the upper half of its reported 52-week range, 42.86% below the high.
$0.10$0.00 (0.0%)
Quantum Genomics S.A.: Healthcare · Biotechnology.
$0.83$0.00 (0.0%)
Curative Biotechnology, Inc.’s quoted price sits in the lower half of its reported 52-week range, 58.32% below the high.
CA$0.04-CA$0.00 (0.0%)
Glow Lifetech Corp.’s quoted price sits in the lower half of its reported 52-week range, 38.46% below the high.
$0.10$0.00 (0.0%)
Chimeric Therapeutics Limited’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.09$0.00 (0.0%)
BioVaxys Technology Corp.’s quoted price sits in the lower half of its reported 52-week range, 73.53% below the high.
$0.02+$0.00 (+13.31%)
Bioxytran, Inc.’s quoted price sits in the lower half of its reported 52-week range, 75.55% below the high.
